Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oral Diabetes Medicine Market Insights, Forecast to 2030

Global Oral Diabetes Medicine Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-26

Pages: 114 Pages

Report ld: 3094149

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Oral Diabetes Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Oral Diabetes Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oral Diabetes Medicine, also provides the sales of main regions and countries. of the upcoming market potential for Oral Diabetes Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Diabetes Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Diabetes Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Diabetes Medicine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Oral Diabetes Medicine Market Insights, Forecast to 2030
Global Oral Diabetes Medicine Companies Covered
Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine
Global Oral Diabetes Medicine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Diabetes Medicine Market, Segment by Type
DPP-4

GLP-1

SGLT-2
Global Oral Diabetes Medicine Market, Segment by Application
Type 1 Diabetes

Type 2 Diabetes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Diabetes Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Diabetes Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Diabetes Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Oral Diabetes Medicine Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Diabetes Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 DPP-4
        1.2.3 GLP-1
        1.2.4 SGLT-2
    1.3 Market by Application
        1.3.1 Global Oral Diabetes Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Type 1 Diabetes
        1.3.3 Type 2 Diabetes
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Oral Diabetes Medicine Sales Estimates and Forecasts 2019-2030
    2.2 Global Oral Diabetes Medicine Revenue by Region
        2.2.1 Global Oral Diabetes Medicine Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Oral Diabetes Medicine Revenue by Region (2019-2024)
        2.2.3 Global Oral Diabetes Medicine Revenue by Region (2025-2030)
        2.2.4 Global Oral Diabetes Medicine Revenue Market Share by Region (2019-2030)
    2.3 Global Oral Diabetes Medicine Sales Estimates and Forecasts 2019-2030
    2.4 Global Oral Diabetes Medicine Sales by Region
        2.4.1 Global Oral Diabetes Medicine Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Oral Diabetes Medicine Sales by Region (2019-2024)
        2.4.3 Global Oral Diabetes Medicine Sales by Region (2025-2030)
        2.4.4 Global Oral Diabetes Medicine Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Oral Diabetes Medicine Sales by Manufacturers
        3.1.1 Global Oral Diabetes Medicine Sales by Manufacturers (2019-2024)
        3.1.2 Global Oral Diabetes Medicine Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Diabetes Medicine in 2023
    3.2 Global Oral Diabetes Medicine Revenue by Manufacturers
        3.2.1 Global Oral Diabetes Medicine Revenue by Manufacturers (2019-2024)
        3.2.2 Global Oral Diabetes Medicine Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Diabetes Medicine Revenue in 2023
    3.3 Global Key Players of Oral Diabetes Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    3.4 Global Oral Diabetes Medicine Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Oral Diabetes Medicine, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Oral Diabetes Medicine, Product Offered and Application
    3.8 Global Key Manufacturers of Oral Diabetes Medicine, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Oral Diabetes Medicine Sales by Type
        4.1.1 Global Oral Diabetes Medicine Historical Sales by Type (2019-2024)
        4.1.2 Global Oral Diabetes Medicine Forecasted Sales by Type (2025-2030)
        4.1.3 Global Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    4.2 Global Oral Diabetes Medicine Revenue by Type
        4.2.1 Global Oral Diabetes Medicine Historical Revenue by Type (2019-2024)
        4.2.2 Global Oral Diabetes Medicine Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    4.3 Global Oral Diabetes Medicine Price by Type
        4.3.1 Global Oral Diabetes Medicine Price by Type (2019-2024)
        4.3.2 Global Oral Diabetes Medicine Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Oral Diabetes Medicine Sales by Application
        5.1.1 Global Oral Diabetes Medicine Historical Sales by Application (2019-2024)
        5.1.2 Global Oral Diabetes Medicine Forecasted Sales by Application (2025-2030)
        5.1.3 Global Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    5.2 Global Oral Diabetes Medicine Revenue by Application
        5.2.1 Global Oral Diabetes Medicine Historical Revenue by Application (2019-2024)
        5.2.2 Global Oral Diabetes Medicine Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    5.3 Global Oral Diabetes Medicine Price by Application
        5.3.1 Global Oral Diabetes Medicine Price by Application (2019-2024)
        5.3.2 Global Oral Diabetes Medicine Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Oral Diabetes Medicine Market Size by Type
        6.1.1 US & Canada Oral Diabetes Medicine Sales by Type (2019-2030)
        6.1.2 US & Canada Oral Diabetes Medicine Revenue by Type (2019-2030)
    6.2 US & Canada Oral Diabetes Medicine Market Size by Application
        6.2.1 US & Canada Oral Diabetes Medicine Sales by Application (2019-2030)
        6.2.2 US & Canada Oral Diabetes Medicine Revenue by Application (2019-2030)
    6.3 US & Canada Oral Diabetes Medicine Market Size by Country
        6.3.1 US & Canada Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Oral Diabetes Medicine Sales by Country (2019-2030)
        6.3.3 US & Canada Oral Diabetes Medicine Revenue by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Oral Diabetes Medicine Market Size by Type
        7.1.1 Europe Oral Diabetes Medicine Sales by Type (2019-2030)
        7.1.2 Europe Oral Diabetes Medicine Revenue by Type (2019-2030)
    7.2 Europe Oral Diabetes Medicine Market Size by Application
        7.2.1 Europe Oral Diabetes Medicine Sales by Application (2019-2030)
        7.2.2 Europe Oral Diabetes Medicine Revenue by Application (2019-2030)
    7.3 Europe Oral Diabetes Medicine Market Size by Country
        7.3.1 Europe Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Oral Diabetes Medicine Sales by Country (2019-2030)
        7.3.3 Europe Oral Diabetes Medicine Revenue by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Oral Diabetes Medicine Market Size
        8.1.1 China Oral Diabetes Medicine Sales  (2019-2030)
        8.1.2 China Oral Diabetes Medicine Revenue  (2019-2030)
    8.2 China Oral Diabetes Medicine Market Size by Application
        8.2.1 China Oral Diabetes Medicine Sales by Application (2019-2030)
        8.2.2 China Oral Diabetes Medicine Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Oral Diabetes Medicine Market Size by Type
        9.1.1 Asia Oral Diabetes Medicine Sales by Type (2019-2030)
        9.1.2 Asia Oral Diabetes Medicine Revenue by Type (2019-2030)
    9.2 Asia Oral Diabetes Medicine Market Size by Application
        9.2.1 Asia Oral Diabetes Medicine Sales by Application (2019-2030)
        9.2.2 Asia Oral Diabetes Medicine Revenue by Application (2019-2030)
    9.3 Asia Oral Diabetes Medicine Sales by Region
        9.3.1 Asia Oral Diabetes Medicine Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Oral Diabetes Medicine Revenue by Region (2019-2030)
        9.3.3 Asia Oral Diabetes Medicine Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Oral Diabetes Medicine Market Size by Type
        10.1.1 Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Oral Diabetes Medicine Market Size by Application
        10.2.1 Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Country
        10.3.1 Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Sanofi Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 Biocon
        11.2.1 Biocon Company Information
        11.2.2 Biocon Overview
        11.2.3 Biocon Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Biocon Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Biocon Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Information
        11.3.2 Boehringer Ingelheim Overview
        11.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Boehringer Ingelheim Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Merck & Co.
        11.4.1 Merck & Co. Company Information
        11.4.2 Merck & Co. Overview
        11.4.3 Merck & Co. Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Merck & Co. Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck & Co. Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Information
        11.5.2 Johnson & Johnson Overview
        11.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Johnson & Johnson Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Information
        11.6.2 Novartis Overview
        11.6.3 Novartis Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Novartis Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novartis Recent Developments
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Company Information
        11.7.2 Novo Nordisk Overview
        11.7.3 Novo Nordisk Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Novo Nordisk Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novo Nordisk Recent Developments
    11.8 Takeda
        11.8.1 Takeda Company Information
        11.8.2 Takeda Overview
        11.8.3 Takeda Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Takeda Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Takeda Recent Developments
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Information
        11.9.2 AstraZeneca Overview
        11.9.3 AstraZeneca Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 AstraZeneca Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 AstraZeneca Recent Developments
    11.10 Huadong Medicine
        11.10.1 Huadong Medicine Company Information
        11.10.2 Huadong Medicine Overview
        11.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 Huadong Medicine Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Huadong Medicine Recent Developments
    11.11 Eli Lilly and Company
        11.11.1 Eli Lilly and Company Company Information
        11.11.2 Eli Lilly and Company Overview
        11.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 Eli Lilly and Company Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Eli Lilly and Company Recent Developments
    11.12 Deyuan Pharmaceutical
        11.12.1 Deyuan Pharmaceutical Company Information
        11.12.2 Deyuan Pharmaceutical Overview
        11.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Deyuan Pharmaceutical Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Deyuan Pharmaceutical Recent Developments
    11.13 Hengrui Medicine
        11.13.1 Hengrui Medicine Company Information
        11.13.2 Hengrui Medicine Overview
        11.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Hengrui Medicine Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hengrui Medicine Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Oral Diabetes Medicine Industry Chain Analysis
    12.2 Oral Diabetes Medicine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Diabetes Medicine Production Mode & Process
    12.4 Oral Diabetes Medicine Sales and Marketing
        12.4.1 Oral Diabetes Medicine Sales Channels
        12.4.2 Oral Diabetes Medicine Distributors
    12.5 Oral Diabetes Medicine Customers

 13 Market Dynamics
    13.1 Oral Diabetes Medicine Industry Trends
    13.2 Oral Diabetes Medicine Market Drivers
    13.3 Oral Diabetes Medicine Market Challenges
    13.4 Oral Diabetes Medicine Market Restraints

 14 Key Findings in The Global Oral Diabetes Medicine Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Diabetes Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of DPP-4
    Table 3. Major Manufacturers of GLP-1
    Table 4. Major Manufacturers of SGLT-2
    Table 5. Global Oral Diabetes Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Oral Diabetes Medicine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Oral Diabetes Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Oral Diabetes Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Oral Diabetes Medicine Revenue Market Share by Region (2019-2024)
    Table 10. Global Oral Diabetes Medicine Revenue Market Share by Region (2025-2030)
    Table 11. Global Oral Diabetes Medicine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Oral Diabetes Medicine Sales by Region (2019-2024) & (K Units)
    Table 13. Global Oral Diabetes Medicine Sales by Region (2025-2030) & (K Units)
    Table 14. Global Oral Diabetes Medicine Sales Market Share by Region (2019-2024)
    Table 15. Global Oral Diabetes Medicine Sales Market Share by Region (2025-2030)
    Table 16. Global Oral Diabetes Medicine Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Oral Diabetes Medicine Sales Share by Manufacturers (2019-2024)
    Table 18. Global Oral Diabetes Medicine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Oral Diabetes Medicine Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Oral Diabetes Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Oral Diabetes Medicine Price by Manufacturers 2019-2024 (US$/Unit)
    Table 22. Global Oral Diabetes Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Oral Diabetes Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Diabetes Medicine as of 2023)
    Table 24. Global Key Manufacturers of Oral Diabetes Medicine, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Oral Diabetes Medicine, Product Offered and Application
    Table 26. Global Key Manufacturers of Oral Diabetes Medicine, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 29. Global Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 30. Global Oral Diabetes Medicine Sales Share by Type (2019-2024)
    Table 31. Global Oral Diabetes Medicine Sales Share by Type (2025-2030)
    Table 32. Global Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Oral Diabetes Medicine Revenue Share by Type (2019-2024)
    Table 35. Global Oral Diabetes Medicine Revenue Share by Type (2025-2030)
    Table 36. Oral Diabetes Medicine Price by Type (2019-2024) & (US$/Unit)
    Table 37. Global Oral Diabetes Medicine Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 38. Global Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 39. Global Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 40. Global Oral Diabetes Medicine Sales Share by Application (2019-2024)
    Table 41. Global Oral Diabetes Medicine Sales Share by Application (2025-2030)
    Table 42. Global Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Oral Diabetes Medicine Revenue Share by Application (2019-2024)
    Table 45. Global Oral Diabetes Medicine Revenue Share by Application (2025-2030)
    Table 46. Oral Diabetes Medicine Price by Application (2019-2024) & (US$/Unit)
    Table 47. Global Oral Diabetes Medicine Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 48. US & Canada Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Oral Diabetes Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Oral Diabetes Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 74. China Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 75. China Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 76. China Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 79. China Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 80. China Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Oral Diabetes Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Oral Diabetes Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Oral Diabetes Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Oral Diabetes Medicine Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Oral Diabetes Medicine Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 108. Sanofi Company Information
    Table 109. Sanofi Description and Major Businesses
    Table 110. Sanofi Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. Sanofi Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi Recent Developments
    Table 113. Biocon Company Information
    Table 114. Biocon Description and Major Businesses
    Table 115. Biocon Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. Biocon Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Biocon Recent Developments
    Table 118. Boehringer Ingelheim Company Information
    Table 119. Boehringer Ingelheim Description and Major Businesses
    Table 120. Boehringer Ingelheim Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. Boehringer Ingelheim Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Boehringer Ingelheim Recent Developments
    Table 123. Merck & Co. Company Information
    Table 124. Merck & Co. Description and Major Businesses
    Table 125. Merck & Co. Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Merck & Co. Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Merck & Co. Recent Developments
    Table 128. Johnson & Johnson Company Information
    Table 129. Johnson & Johnson Description and Major Businesses
    Table 130. Johnson & Johnson Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 131. Johnson & Johnson Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Johnson & Johnson Recent Developments
    Table 133. Novartis Company Information
    Table 134. Novartis Description and Major Businesses
    Table 135. Novartis Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 136. Novartis Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Novartis Recent Developments
    Table 138. Novo Nordisk Company Information
    Table 139. Novo Nordisk Description and Major Businesses
    Table 140. Novo Nordisk Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 141. Novo Nordisk Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Novo Nordisk Recent Developments
    Table 143. Takeda Company Information
    Table 144. Takeda Description and Major Businesses
    Table 145. Takeda Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 146. Takeda Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Takeda Recent Developments
    Table 148. AstraZeneca Company Information
    Table 149. AstraZeneca Description and Major Businesses
    Table 150. AstraZeneca Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 151. AstraZeneca Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. AstraZeneca Recent Developments
    Table 153. Huadong Medicine Company Information
    Table 154. Huadong Medicine Description and Major Businesses
    Table 155. Huadong Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 156. Huadong Medicine Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Huadong Medicine Recent Developments
    Table 158. Eli Lilly and Company Company Information
    Table 159. Eli Lilly and Company Description and Major Businesses
    Table 160. Eli Lilly and Company Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 161. Eli Lilly and Company Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Eli Lilly and Company Recent Developments
    Table 163. Deyuan Pharmaceutical Company Information
    Table 164. Deyuan Pharmaceutical Description and Major Businesses
    Table 165. Deyuan Pharmaceutical Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 166. Deyuan Pharmaceutical Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Deyuan Pharmaceutical Recent Developments
    Table 168. Hengrui Medicine Company Information
    Table 169. Hengrui Medicine Description and Major Businesses
    Table 170. Hengrui Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 171. Hengrui Medicine Oral Diabetes Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Hengrui Medicine Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Oral Diabetes Medicine Distributors List
    Table 176. Oral Diabetes Medicine Customers List
    Table 177. Oral Diabetes Medicine Market Trends
    Table 178. Oral Diabetes Medicine Market Drivers
    Table 179. Oral Diabetes Medicine Market Challenges
    Table 180. Oral Diabetes Medicine Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Diabetes Medicine Product Picture
    Figure 2. Global Oral Diabetes Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oral Diabetes Medicine Market Share by Type in 2023 & 2030
    Figure 4. DPP-4 Product Picture
    Figure 5. GLP-1 Product Picture
    Figure 6. SGLT-2 Product Picture
    Figure 7. Global Oral Diabetes Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Oral Diabetes Medicine Market Share by Application in 2023 & 2030
    Figure 9. Type 1 Diabetes
    Figure 10. Type 2 Diabetes
    Figure 11. Oral Diabetes Medicine Report Years Considered
    Figure 12. Global Oral Diabetes Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Oral Diabetes Medicine Revenue 2019-2030 (US$ Million)
    Figure 14. Global Oral Diabetes Medicine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Oral Diabetes Medicine Revenue Market Share by Region (2019-2030)
    Figure 16. Global Oral Diabetes Medicine Sales 2019-2030 ((K Units)
    Figure 17. Global Oral Diabetes Medicine Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Oral Diabetes Medicine Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Oral Diabetes Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Oral Diabetes Medicine Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Oral Diabetes Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Oral Diabetes Medicine Sales YoY (2019-2030) & (K Units)
    Figure 23. China Oral Diabetes Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Oral Diabetes Medicine Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Oral Diabetes Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Oral Diabetes Medicine Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Oral Diabetes Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Diabetes Medicine in the World: Market Share by Oral Diabetes Medicine Revenue in 2023
    Figure 30. Global Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 32. Global Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 33. Global Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 34. Global Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Oral Diabetes Medicine Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Oral Diabetes Medicine Sales Share by Country (2019-2030)
    Figure 41. U.S. Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 44. Europe Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 46. Europe Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Oral Diabetes Medicine Revenue Share by Country (2019-2030)
    Figure 48. Europe Oral Diabetes Medicine Sales Share by Country (2019-2030)
    Figure 49. Germany Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 50. France Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 54. China Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 55. China Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 56. China Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 57. China Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 59. Asia Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 61. Asia Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Oral Diabetes Medicine Revenue Share by Region (2019-2030)
    Figure 63. Asia Oral Diabetes Medicine Sales Share by Region (2019-2030)
    Figure 64. Japan Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 68. India Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Oral Diabetes Medicine Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Oral Diabetes Medicine Sales Share by Country (2019-2030)
    Figure 75. Brazil Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Oral Diabetes Medicine Revenue (2019-2030) & (US$ Million)
    Figure 80. Oral Diabetes Medicine Value Chain
    Figure 81. Oral Diabetes Medicine Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

Description

The global Oral Diabetes Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Oral Diabetes Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Descriptive company profiles of the major global players, including Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc.

Market Segmentation